Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-009-0837-yPMID 19946789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small Colony Variants: a Pathogenic Form of Bacteria that Facilitates Persistent and Recurrent Infections

  2009cited by this paper
• Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Clones Collected in France in 2006 and 2007

  2008cited by this paper
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cited by this paper
• Treatment of joint prosthesis infection in accordance with current recommendations improves outcome.

  2008cited by this paper
• Methicillin-Resistant Staphylococcus aureus, Geneva, Switzerland, 1993–2005

  2008cited by this paper
• Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2007cited by this paper
• Higher Risk of Failure of Methicillin-resistant Staphylococcus aureus Prosthetic Joint Infections

  2007cited by this paper
• Toxin Gene Content of the Lyon Methicillin-Resistant Staphylococcus aureus Clone Compared with That of Other Pandemic Clones

  2006influential reference
• Combination of Multiplex PCRs for Staphylococcal Cassette Chromosome mec Type Assignment: Rapid Identification System for mec, ccr, and Major Differences in Junkyard Regions

  2006cited by this paper
• Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections

  2006cited by this paper
• Outcome of prosthetic joint infections treated with debridement and retention of components.

  2006cited by this paper
• Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology.

  2006influential reference
• Use of an Automated Multiple-Locus, Variable-Number Tandem Repeat-Based Method for Rapid and High-Throughput Genotyping of Staphylococcus aureus Isolates

  2005cited by this paper
• The predominant variant of the Brazilian epidemic clonal complex of methicillin-resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells.

  2005cited by this paper
• Osteomyelitis.

  2004cited by this paper
• Prosthetic-joint infections.

  2004cited by this paper
• Management of Infection Associated with Prosthetic Joints

  2003cited by this paper
• Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists.

  2003cited by this paper
• Results of Periprosthetic Hip and Knee Infections Caused by Resistant Bacteria

  2002cited by this paper
• Relationships between Staphylococcus aureus Genetic Background, Virulence Factors, agr Groups (Alleles), and Human Disease

  2002cited by this paper
• New developments in diagnosis and treatment of infection in orthopedic implants.

  2001influential reference
• Pharmacodynamics of Glycopeptides in the Mouse Peritonitis Model of Streptococcus pneumoniae orStaphylococcus aureus Infection

  2000influential reference
• Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.

  1998cited by this paper
• Risk factors for prosthetic joint infection: case-control study.

  1998cited by this paper
• Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention.

  1997cited by this paper
• Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin.

  1997cited by this paper
• The Risk of Determining Risk with Multivariable Models

  1993cited by this paper
• Suppressive antibiotic therapy in chronic prosthetic joint infections.

  1991cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper
• Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.

  1990cited by this paper
• Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection

  1990cited by this paper
• Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases.

  1990cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Biomaterial-centered infection: microbial adhesion versus tissue integration.

  1987cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Molecular Evolution of Mrsa Secrets of Success of a Human Pathogen: Molecular Evolution of Pandemic Clones of Meticillin- Resistant Staphylococcus Aureus

  year unknowncited by this paper

• Evaluating the Link Between Postoperative Timing of Rifampicin Introduction and the Clinical and Microbiological Outcomes of Orthopedic Staphylococcal Implant Infections

  2025cites this paper
• Methicillin-sensitive Staphylococcus aureus lineages contribute towards poor patient outcomes in orthopaedic device-related infections

  2025cites this paper
• Antibiotics with antibiofilm activity – rifampicin and beyond

  2024cites this paper
• A Comparison of the Minimum Inhibitory Concentration of Antibiotics in Staphylococcus Species Isolated From Orthopedic and Respiratory Medicine Infections

  2023cites this paper
• Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot

  2022cites this paper
• Polycaprolactone-Coated Alginate/b-Tricalcium Phosphate Beads to Locally Deliver Vancomycin: A Pilot Study

  2022cites this paper
• What Is the Most Effective Empirical Antibiotic Treatment for Early, Delayed, and Late Fracture-Related Infections?

  2022cites this paper
• Point-Counterpoint: Should Clinical Microbiology Laboratories Report Vancomycin MICs?

  2021cites this paper
• Novel strategies to diagnose prosthetic or native bone and joint infections

  2021cites this paper
• Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid

  2021cites this paper
• Staphylococcus aureus native arthritis over 10 years.

  2020cites this paper
• Lack of Humoral Immunity Against Glucosaminidase Is Associated with Postoperative Complications in Staphylococcus aureus Osteomyelitis.

  2020cites this paper
• Genotypic and Phenotypic Characteristics of Staphylococcus aureus Prosthetic Joint Infections: Insight on the Pathogenesis and Prognosis of a Multicenter Prospective Cohort

  2020cites this paper
• Temporal Changes in Patient-Matched Staphylococcus epidermidis Isolates from Infections: towards Defining a ‘True’ Persistent Infection

  2020cites this paper
• Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.

  2020cites this paper
• Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis.

  2020cites this paper
• DAIR (Debridement, Antibiotics and Implant Retention) less effective in hematogenous total knee arthroplasty infections

  2019cites this paper
• Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study.

  2019cites this paper
• The Benefice of Mobile Parts’ Exchange in the Management of Infected Total Joint Arthroplasties with Prosthesis Retention (DAIR Procedure)

  2019cites this paper
• Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)

  2019cites this paper
• Successful 6-Week Antibiotic Treatment for Early Surgical-site Infections in Spinal Surgery.

  2018cites this paper
• Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review

  2018cites this paper
• Immunotherapy synergizes with debridement and antibiotic therapy in a murine 1‐stage exchange model of MRSA implant‐associated osteomyelitis

  2018cites this paper
• Non-compliance with IDSA guidelines for patients presenting with methicillin-susceptible Staphylococcus aureus prosthetic joint infection is a risk factor for treatment failure.

  2017cites this paper
• The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement – a literature review

  2017cites this paper
• Influence of molecular characteristics in the prognosis of methicillin-resistant Staphylococcus aureus prosthetic joint infections: beyond the species and the antibiogram

  2017cites this paper
• Mechanisms of drug–drug interaction between rifampicin and fusidic acid

  2017cites this paper
• Staphylococcus aureus soft tissue infection may increase the risk of subsequent staphylococcal soft tissue infections.

  2017cites this paper
• Surface topography of silicon nitride affects antimicrobial and osseointegrative properties of tibial implants in a murine model.

  2017cites this paper
• A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.

  2016cites this paper
• Burden of Surgical Site Infections Associated with Arthroplasty and the Contribution of Staphylococcus aureus

  2016influential citation
• Chapter 16 – The Role of the Immune System and Bone Cells in Acute and Chronic Osteomyelitis

  2016cites this paper
• Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

  2016cites this paper
• Success With Extended-Infusion Meropenem After Recurrence of Baclofen Pump-Related Achromobacter Xylosoxidans Meningitis in an Adolescent

  2015cites this paper
• Efficacy of Single-stage Revision with Aggressive Debridement Using Intra-articular Antibiotics in the Treatment of Infected Joint Prosthesis

  2015cites this paper
• An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future

  2015cites this paper
• Oral antibiotic therapy.

  2014cites this paper
• Passive immunization with anti‐glucosaminidase monoclonal antibodies protects mice from implant‐associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters

  2014cites this paper
• Antibiotics in Treatment of Periprosthetic Joint Infections

  2014cites this paper
• Oral antibiotic treatment of staphylococcal bone and joint infections in adults.

  2014cites this paper
• Modern Antibiotic Treatment of Chronic Long Bone Infections in Adults-Theory, Evidence and Practice

  2014cites this paper
• Staphylococcus aureus for Biofilm-Embedded Methicillin-Resistant of Rifampin-Based Combination Regimens Efficacies and Resistance Profiles In Vitro

  2014cites this paper
• Do Diabetic Foot Infections With Methicillin-Resistant Staphylococcus aureus Differ From Those With Other Pathogens?

  2014cites this paper
• Workgroup 14 : Oral Antibiotic Therapy Liaison :

  2014cites this paper
• Other Pathogens ? Differ From Those With Staphylococcus aureus Do Diabetic Foot Infections With Methicillin-Resistant

  2014cites this paper
• Oral Antibiotic Therapy

  2014cites this paper
• Risk Factors for Failure in Early Prosthetic Joint Infection Treated with Debridement. Influence of Etiology and Antibiotic Treatment

  2014cites this paper
• A new strategy to fight antimicrobial resistance: the revival of old antibiotics

  2014cites this paper
• Clinical experience with linezolid for the treatment of orthopaedic implant infections.

  2014cites this paper
• A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention

  2013cites this paper
• Prosthetic joint infections due to methicillin-resistant and methicillin-susceptible staphylococci treated with open debridement and retention of the prosthesis.

  2013cites this paper
• A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.

  2013cites this paper
• High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

  2013cites this paper
• In Vitro Efficacies and Resistance Profiles of Rifampin-Based Combination Regimens for Biofilm-Embedded Methicillin-Resistant Staphylococcus aureus

  2013cites this paper
• Biofilm-Embedded Methicillin-Resistant Staphylococcus aureus 2

  2013cites this paper
• Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression.

  2012cites this paper
• Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.

  2012cites this paper
• Prosthetic Joint Infections due to Staphylococcus Aureus and Coagulase-Negative Staphylococci

  2012cites this paper
• Outcome of Debridement and Retention in Prosthetic Joint Infections by Methicillin-Resistant Staphylococci, with Special Reference to Rifampin and Fusidic Acid Combination Therapy

  2012cites this paper
• eview usidic acid for the treatment of bone and joint infections caused by eticillin-resistant Staphylococcus aureus

  2012cites this paper
• The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

  2012cites this paper
• usidic acid for the treatment of bone and joint infections caused by eticillin-resistant Staphylococcus aureus

  2012cites this paper
• Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study

  2012cites this paper
• Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus

  2012influential citation
• Antibiotische Infektionsprophylaxe in der Primär- und Revisionsendoprothetik der Hüfte

  2011cites this paper
• Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus

  2011cites this paper
• The Role of the Immune System and Bone Cells in Acute and Chronic Osteomyelitis

  2011cites this paper
• Oral Agents for the Treatment of Orthopedic Infections Caused by Methicillin-resistant Staphylococci

  2011cites this paper
• Quantitative analysis of biofilm formation of methicillin-resistant Staphylococcus aureus (MRSA) strains from patients with orthopaedic device-related infections.

  2011cites this paper
• Linezolid plus Rifampin as a Salvage Therapy in Prosthetic Joint Infections Treated without Removing the Implant

  2011cites this paper
• Treated without Removing the Implant Therapy in Prosthetic Joint Infections Linezolid plus Rifampin as a Salvage

  2011cites this paper
• High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus

  2011cites this paper
• Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges

  2010cites this paper
• Underestimation of Vancomycin and Teicoplanin MICs by Broth Microdilution Leads to Underdetection of Glycopeptide-Intermediate Isolates of Staphylococcus aureus

  2010cites this paper